Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $93.1100 (2%) ($93.1100 - $93.4200) on Thu. Oct. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.63% (three month average) | RSI | 71 | Latest Price | $93.1100(2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 5.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(49%) IWN(48%) IWO(48%) IWC(45%) SDY(43%) | Factors Impacting LGND price | LGND will decline at least -1.315% in a week (0% probabilities). VXX(-16%) UUP(-13%) UNG(-7%) TBT(-5%) VIXM(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.315% (StdDev 2.63%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $92.79(0.34%) | 10 Day Moving Average | $92.4(0.77%) | 20 Day Moving Average | $88.1(5.69%) | To recent high | -13.5% | To recent low | 19.9% | Market Cap | $1.496b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |